Sat.Jul 15, 2023 - Fri.Jul 21, 2023

article thumbnail

Molecules of the Month – June 2023

Drug Hunter

With the popular success of diabetes and weight-loss peptide drugs from Novo (e.g. semaglutide/Ozempic), this month features a pair of ultra-hot non-peptide oral GLP-1R modulators in clinical development. Other notable Molecules of the Month include vorasidenib, which demonstrated headline-generating efficacy in brain cancers, as well as controversial billion-dollar molecule atrasentan, the subject of a short-seller report by Muddy Waters.

article thumbnail

U.S Government Wants Reasonably Priced Covid-19 Vaccines

Forbes: Drug Truths

Unfortunately, Becerra’s rhetoric reinforces many misconceptions about the history of the discovery and development of the Covid-19 vaccines, work that was critical in.

Vaccine 202
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novartis buys a preclinical biotech and its RNA drug technology

BioPharma Drive: Drug Pricing

For $500 million, Novartis will acquire DTx Pharma and its preclinical neurological disease drugs, marking the Swiss company’s latest investment in gene-silencing medicines.

RNA 98
article thumbnail

How Prior Auth Solutions Can Empower Patients, Providers and Pharma Field Teams

Drug Channels

Today’s guest post comes from Brent Clifton, Vice President of Product Management at CoverMyMeds. Brent discusses the challenges that patients, caregivers, and providers face when seeking access to medications requiring prior authorization. He explains how an electronic prior authorization solution can reduce delays and help patients start their therapies sooner—especially when patients and brands can play an active role in the process.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

A look back at the first year of NeuroDev

Broad Institute

A look back at the first year of NeuroDev By Makenzie Kohler July 20, 2023 Breadcrumb Home A look back at the first year of NeuroDev Researchers are working to characterize the genetic and phenotypic data of people with neurodevelopmental conditions in Kenya and South Africa. By Makenzie Kohler July 20, 2023 Credit: Aga Khan University Institute for Human Development NeuroDev researchers from Kenya, South Africa, and the United States at a meeting in Nairobi, Kenya.

article thumbnail

Fattening Doctors To Promote Weight Loss Drugs

Forbes: Drug Truths

In order to promote its weight-loss and diabetes drugs, Novo Nordisk bought doctors almost a half a million meals in 2022.

Doctors 188

More Trending

article thumbnail

Life on Earth didn't arise as described in textbooks

Science Daily: Pharmacology News

No, oxygen didn't catalyze the swift blossoming of Earth's first multicellular organisms. The result defies a 70-year-old assumption about what caused an explosion of oceanic fauna hundreds of millions of years ago.

98
article thumbnail

Researchers reprogram gene therapy viral vectors to bind specific protein targets

Broad Institute

Researchers reprogram gene therapy viral vectors to bind specific protein targets By Allessandra DiCorato July 19, 2023 Breadcrumb Home Researchers reprogram gene therapy viral vectors to bind specific protein targets A new screening method zeroes in on adeno-associated viruses that enter the brain through a defined mechanism. By Allessandra DiCorato July 19, 2023 Credit: Kevin Middleton, Broad Communications A three-dimensional model of adeno-associated viruses (AAVs), which scientists have eng

article thumbnail

Discover How Katie Burwell Shapes Perficient’s Inclusive Culture

Perficient: Drug Development

Perficient is proud of our people-first, award-winning culture that promises to challenge, champion, and celebrate all our colleagues. Perficient is always looking to hire thought leaders and difference makers, and therefore, identifying top talent is essential to our mission. Katie Burwell , a senior talent acquisition specialist, is helping to grow our talented team of experts.

98
article thumbnail

Pfizer, Flagship join forces to hunt for 10 new drugs

BioPharma Drive: Drug Pricing

The unusual research alliance involves the startup creator’s Pioneering Medicines initiative, which previously struck pacts with Novo Nordisk and the Cystic Fibrosis Foundation.

Drugs 98
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Navigating the challenges and opportunities of AI in drug development and personalised medicine

Drug Target Review

Artificial Intelligence (AI) is poised to transform the field of target discovery in drug development, offering immense potential to enhance efficacy, personalised medicine, and accelerate the development of innovative compounds. However, as AI becomes increasingly integrated into the drug discovery process , challenges related to data quality, collaboration, and regulatory adaptation need to be addressed to ensure its successful implementation.

article thumbnail

Stretch Your Brain as You Age, Lower Your Dementia Risk?

Drugs.com

MONDAY, July 17, 2023 -- Writing letters, taking classes and playing mentally stimulating games like chess in your older years could lower your risk of dementia over the next decade, a new study suggests. Researchers in Australia found that.

article thumbnail

Four Crucial Questions about the Humira Biosimilar Price War

Drug Channels

The Humira biosimilar market has arrived! This month, nine biosimilar versions of adalimumab launched in the U.S. market. As I predicted in 2021 , some products launched with list prices that are only slightly lower than Humira’s list price, while others are trying to tempt payers and pharmacy benefit manages (PBMs) with deep list price discounts. Surprisingly, two PBMs—Express Scripts and OptumRx—will each offer at least one low-list-price biosimilar option on their main national formularies.

article thumbnail

The study of the microbiota-gut-brain axis (MGBA) in Zebrafish

biobide

The Microbiota-Gut-Brain axis (MGBA) is a topic of interest that has gained attention and recognition in the scientific community over the past years. The gut–brain axis includes the central nervous, endocrine, and immune systems, and it is an information exchange network that connects the gut and the brain. It can transmit information bidirectionally: “top–down” from the brain to the gut and “bottom–up” from the gut to the brain.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Apellis shares sink on reports of rare side effects with new vision loss drug

BioPharma Drive: Drug Pricing

An organization of retinal specialists flagged six cases of severe eye inflammation from commercial use of Syfovre. Apellis says the drug’s safety profile is consistent with testing.

Drugs 97
article thumbnail

Fluoride Toothpaste, Make Room for a New Competitor

Drugs.com

TUESDAY, July 18, 2023 -- Fluoride may have found its match in preventing cavities. New research shows that toothpaste containing hydroxyapatite, one of the main mineral components in teeth, can prevent cavities as effectively as fluoride, which has.

article thumbnail

Addressing the grand challenge of global access to vaccines

Drug Target Review

The mad scramble 1 for -80°C freezers during the COVID-19 pandemic is a vivid illustration that we remain unprepared to harness the global potential of vaccine therapeutics. Although it is true that requirements have since been relaxed for those particular vaccines, cold-chain distribution remains a major barrier that has drawn significant funding, including from Bill Gates. 2 However, it is not just problematic cold chains that limit access to life-saving vaccines.

Vaccine 96
article thumbnail

The Pacific slope of Peru is greening, and this is not good news

SCIENMAG: Medicine & Health

Analysing satellite data spanning the past 20 years, the research team based at the Cavendish Laboratory in Cambridge examined how vegetation has been changing along the Pacific coast of Peru and northern Chile. This area is known for its unique and delicate arid and semi-arid environments.

article thumbnail

Idorsia warns of up to 500 layoffs as part of cost-cutting initiative

BioPharma Drive: Drug Pricing

The Swiss drugmaker now joins a lengthy list of biotechs that, amid a drawn-out market downturn, have turned to job cuts and research re-evaluations to save money.

article thumbnail

AHA News: Woman Survives Stroke in 2 Parts of the Brain at Age 29

Drugs.com

WEDNESDAY, July 19, 2023 (American Heart Association News) -- After a night of partying, 29-year-old Bethany Moeddel felt nauseous and had a headache. A hangover, she figured. She couldn't sleep it off, though, because it was a big day. Her.

98
article thumbnail

Overriding Optimizely’s Content Recommendations Block to Implement Custom Recommendations

Perficient: Drug Development

Introduction The Content Recommendations add-on for Optimizely CMS dynamically recommends content from your site tailored to the interests of each user. Installing the NuGet Package will give you access to Optimizely’s Content Recommendations Block which uses Mustache Templating to render the data from the Content Recommendations API on a page. Although Mustache Templates provide a great way of inserting recommendation data into a webpage, content authors who don’t have prior experience wi

article thumbnail

Plenary closeup: Biomolecular condensates the foundation for innovations to come

SCIENMAG: Medicine & Health

Biomolecular condensates, the tiny combinations of proteins and mRNA forming membrane-less compartments within cells, have big potential implications for the future of not just plants but humans.

article thumbnail

Westlake raises $450M in latest biotech venture fund

BioPharma Drive: Drug Pricing

Leaders from the firm said that, despite a turbulent biotech market, most of their existing limited partners returned to participate in the new fund, which will support approximately a dozen startups.

article thumbnail

Scientists Spot 32 Proteins That Hint at Alzheimer's Risk

Drugs.com

THURSDAY, July 20, 2023 -- It’s difficult to fully predict who will develop Alzheimer’s disease in advance. Now, a new study suggests that certain markers in the blood may occur 10 to 20 years before the start of symptoms and could help.

Disease 98
article thumbnail

From Bench to Bedside and Back Again: Strategies for Effectively Leveraging Pre-Clinical Data to Accelerate R&D

Fierce BioTech

From Bench to Bedside and Back Again: Strategies for Effectively Leveraging Pre-Clinical Data to Accelerate R&D dwunderlin Mon, 07/17/2023 - 16:55 Thu, 09/07/2023 - 11:00 Resource Type Webinar Duration 60 Minutes The drug discovery process is complex and time-consuming, with an average development time of 10+ years and hundreds of millions to billions of dollars spent to receive regulatory approval.

article thumbnail

New research shows babies’ immunological weak spot and strength

SCIENMAG: Medicine & Health

NEW YORK, NY–A pair of new studies led by researchers at Columbia University explains why babies get so many common respiratory infections and identifies a specialized cluster of immune cells found only in babies that help them better cope with new pathogens.

article thumbnail

A cancer biotech’s collapse gives Neurogene a path to Wall Street

BioPharma Drive: Drug Pricing

The startup, a developer of gene therapies for brain diseases like Rett Syndrome, will bypass an IPO by merging with struggling cancer drugmaker Neoleukin.

article thumbnail

Experimental Shot Given Every Six Months Controlled High Blood Pressure in Early Trial

Drugs.com

THURSDAY, July 20, 2023 -- Every day, millions of people must take one or more pills to control their blood pressure and reduce their risk for heart attack or stroke, but if new research pans out, some may be able to scrap their pills for a.

Trials 98
article thumbnail

Greenland melted recently, shows high risk of sea level rise today

Science Daily: Pharmacology News

A large portion of Greenland was an ice-free tundra landscape -- perhaps covered by trees and roaming woolly mammoths -- in the recent geologic past (about 416,000 years ago), a new study shows. The results help overturn a previous view that much of the Greenland ice sheet persisted for most of the last two and a half million years. Instead, moderate warming, from 424,000 to 374,000 years ago, led to dramatic melting.

98
article thumbnail

Simultaneous synthesis and fixing of covalent organic frameworks

SCIENMAG: Medicine & Health

Covalent organic frameworks (COFs) are versatile materials composed of interconnected organic molecules held together by covalent bonds. These frameworks can be constructed in two-dimensional or three-dimensional (3D) forms which possess a unique combination of low density, high surface area, and easily tunable properties.

94
article thumbnail

Sanofi expands research deal with gene editing startup Scribe

BioPharma Drive: Drug Pricing

Scribe will receive $40 million upfront from Sanofi in a collaboration initially focused on developing an in vivo gene editing treatment for sickle cell disease.

article thumbnail

AHA News: Warnings – And Hope – From New Heart Disease Treatment Guidelines

Drugs.com

THURSDAY, July 20, 2023 (American Heart Association News) -- New guidelines detailing how to care for people with heart disease come with some easy-to-grasp warnings for patients. The chronic coronary disease guidelines from the American Heart.

Disease 98
article thumbnail

New patent expiration for Genzyme drug MOZOBIL

Drug Patent Watch

Annual Drug Patent Expirations for MOZOBIL Mozobil is a drug marketed by Genzyme and is included in one NDA. It is available from two suppliers. There are two patents protecting… The post New patent expiration for Genzyme drug MOZOBIL appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 79
article thumbnail

A cool way to keep things cool: the electrocaloric effect

SCIENMAG: Medicine & Health

As necessary as cooling technologies are, we’re still operating on an outdated technology that can be considered a significant contributor to global warming and greenhouse gas emissions.